相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer
Joseph Sia et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Genome-Wide Transcriptomic Analysis Identifies Pathways Regulated by Sterculic Acid in Retinal Pigmented Epithelium Cells
Ana Pariente et al.
CELLS (2020)
Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting
Joana Vieira de Castro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Therapy for glioblastoma: is it working?
Edward D. Zanders et al.
DRUG DISCOVERY TODAY (2019)
Impact of overall corticosteroid exposure during chemoradiotherapy on lymphopenia and survival of glioblastoma patients
Caressa Y. Hui et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies
Marta Cenciarini et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature
Salvatore Grisanti et al.
JOURNAL OF NEUROSURGICAL SCIENCES (2019)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
Mapping Mitotic Death: Functional Integration of Mitochondria, Spindle Assembly Checkpoint and Apoptosis
Weimei Ruan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Dexamethasone-induced leukocytosis is associated with poor survival in newly diagnosed glioblastoma
Daniel Dubinski et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma
Markus M. Luedi et al.
JOURNAL OF NEUROSURGERY (2018)
A PDGFRα-driven mouse model of glioblastoma reveals a stathmin1-mediated mechanism of sensitivity to vinblastine
Hyun Jung Jun et al.
NATURE COMMUNICATIONS (2018)
PDGFR and IGF-1R Inhibitors Induce a G2/M Arrest and Subsequent Cell Death in Human Glioblastoma Cell Lines
Estefania Carrasco-Garcia et al.
CELLS (2018)
Combination therapy to checkmate Glioblastoma: clinical challenges and advances
Debarati Ghosh et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Glucose availability controls ATF4-mediated MITF suppression to drive melanoma cell growth
Jennifer Ferguson et al.
ONCOTARGET (2017)
Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells
Alejandra M. Petrilli et al.
ONCOTARGET (2017)
In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment
Guranda Chitadze et al.
ONCOIMMUNOLOGY (2017)
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
Qianghu Wang et al.
CANCER CELL (2017)
Corticosteroids compromise survival in glioblastoma
Kenneth L. Pitter et al.
BRAIN (2016)
mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance
Laura Garros-Regulez et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Different cell fates after mitotic slippage: From aneuploidy to polyploidy
Akihiro Ohashi
MOLECULAR & CELLULAR ONCOLOGY (2016)
Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma (vol 113, pg 232, 2015)
E. T. Wong et al.
BRITISH JOURNAL OF CANCER (2015)
MYC Is a Major Determinant of Mitotic Cell Fate
Caroline Topham et al.
CANCER CELL (2015)
MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide
Oihane Erice et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
Daniel J. Brat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients
Lisa B. E. Shields et al.
RADIATION ONCOLOGY (2015)
Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis
Loyola V. Gressot et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Medical management of brain tumors and the sequelae of treatment
David Schiff et al.
NEURO-ONCOLOGY (2015)
Most Human Non-GCIMP Glioblastoma Subtypes Evolve from a Common Proneural-like Precursor Glioma
Tatsuya Ozawa et al.
CANCER CELL (2014)
A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07)
Markus Hutterer et al.
NEURO-ONCOLOGY (2014)
Sunitinib administered prior to radiotherapy in patients with non-resectable glioblastoma: results of a Phase II study
Carmen Balana et al.
TARGETED ONCOLOGY (2014)
Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution
Signe Regner Michaelsen et al.
BMC CANCER (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter
Khatri Latha et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Continuous daily sunitinib for recurrent glioblastoma
Teri Nguyen Kreisl et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Structural and Functional Properties of Platelet-Derived Growth Factor and Stem Cell Factor Receptors
Carl-Henrik Heldin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
A prospective phase II single-institution trial of sunitinib for recurrent malignant glioma
Edward Pan et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Sunitinib in Metastatic Renal Cell Carcinoma Patients With Brain Metastases
Martin E. Gore et al.
CANCER (2011)
Comparison of Corticotropin-Releasing Factor, Dexamethasone, and Temozolomide: Treatment Efficacy and Toxicity in U87 and C6 Intracranial Gliomas
Maxim A. Moroz et al.
CLINICAL CANCER RESEARCH (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine
Stefano Santaguida et al.
JOURNAL OF CELL BIOLOGY (2010)
Imatinib Upregulates Compensatory Integrin Signaling in a Mouse Model of Gastrointestinal Stromal Tumor and Is More Effective When Combined with Dasatinib
Ferdinand Rossi et al.
MOLECULAR CANCER RESEARCH (2010)
The Aurora B kinase activity is required for the maintenance of the differentiated state of murine myoblasts
G. Amabile et al.
CELL DEATH AND DIFFERENTIATION (2009)
Src kinases as therapeutic targets for cancer
Lori C. Kim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Modeling Adult Gliomas Using RCAS/t-va Technology
Dolores Hambardzumyan et al.
TRANSLATIONAL ONCOLOGY (2009)
Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment
Jerome Villeneuve et al.
BRAIN PATHOLOGY (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Bub1 is required for kinetochore localization of BubR1, Cenp-E, Cenp-F and Mad2, and chromosome congression
VL Johnson et al.
JOURNAL OF CELL SCIENCE (2004)
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo
C Dai et al.
GENES & DEVELOPMENT (2001)
分享论文
